SUGGESTED ROUTING
Senior Management
Advertising
Continuing Education
Corporate Finance
Executive Representatives
Government Securities
Institutional
Insurance
Internal Audit
Legal & Compliance
Municipal
Mutual Fund
Operations
Options
Registered
(a) Definitions
For purposes of this Rule, the following terms shall be defined as provided.
(1) "Emerging Growth Company" has the same meaning as in Section 3(a)(80) of the Exchange Act.
(2) "Equity security" has the same meaning as defined in Section 3(a)(11) of the Exchange Act.
(3) "Independent third-party research report" means a third-party research report
Im writing to provide strong rebuke of FINRAs Regulatory Notice 22-08 and its attempt to limit investors/traders (I/Ts). What FINRA is proposing is tantamount to treating I/Ts like immature children. Its highly evident in the statement FINRA released: However, important regulatory concerns arise when investors trade complex products without understanding their unique characteristics and risks.
Hello, In regards to the Regulatory Notice issued by the Financial Industry Regulatory Authority (FINRA) on March 8, 2022, I would like to express my concern as to the potential limits this rule will impose on some investors for buying and selling of the leveraged and inverse funds or other products deemed to be complex in nature. I regularly use these products as a focal point of my trading
I am deeply disturbed by the proposed regulation limiting access to leveraged and inverse ETFs (which are publicly-traded securities) to those with high net worth who pass a specialized regulatory exam and then jump through a series of administrative and timing-related hoops.
Leveraged and inverse ETFs are one of the few methods that the little guy has in order to protect his or her investments
I am extremely disappointed to hear about yet another regulation to come from this already overreaching authority. I am an individual investor and these leveraged products have played an important role in my portfolio for over a decade. I have used them to both limit my risk and to enhance returns. As an example, I wanted exposure to the S&P 500 but also wanted to hedge a portion of
I appreciate FINRAs concern regarding complex products. In this case, I think it is entirely inappropriate to place any restrictions them buying these types of products, but warnings would be helpful. I believe this for a number of reasons:
1.Restrictions hurt investors by taking away options. For me in particular, restricting access to purchase these products may ruin 10 years of work and a
I strongly support FINRA's mission to protect investors from ensuring an open, honest, and fair securities market, a key piece of which is striving to align investor needs and goals with product choice. It is probably or even likely that "complex" products are not appropriate for most investors, and to that end these products are broadly not used by most investors. Few defined
On February 1, 2018, FINRA will introduce two new TRACE data products: the End-of-Day TRACE Transaction File and the TRACE Security Activity Report.
The End-of-Day TRACE Transaction File
The new End-of-Day TRACE Transaction File is a daily file that includes all transaction data disseminated as part of Real-Time TRACE transaction data on that day. The End-of-Day TRACE Transaction File will be
Is anything going on with regards to investigating ‘meme’ stocks AMC and GME? There is so much fraudulent manipulation of the stock prices I. A daily basis. I’ve seen this for months. I’m no expert but have educated myself to being able to read a stock chart and basic corresponding numbers. Daily - —ladder attacks - buy/sell of millions of shares, or continuous sell orders that are canceled
